Author response for 'Findings for iGlarLixi vs BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics'

Autor:	null Philip D. Home, null Rory J. McCrimmon, null Julio Rosenstock, null Matthias Blüher, null Katrin Pegelow, null Lydie Melas‐Melt, null Khier Djaballah, null Francesco Giorgino, null the SoliMix trial investigators
Rok vydání:	2022
DOI:	10.1111/dom.14907/v2/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::d68e8d570a2f53dc8df75c0792d2129c https://doi.org/10.1111/dom.14907/v2/response1 Zobrazit plný text záznamu